Will Carroll, PharmD, has joined Sacramento, Calif.-based Sutter Health as vice president and chief pharmacy officer after three years at Edison, N.J.-based Hackensack Meridian Health.  Dr. Carroll assumed his new role Nov. 3, according to a spokesperson for the 27-hospital…

Ultra high-cost drugs, or medications that cost more than $1 million per patient, can be life-altering treatments. They are also covered in an obsolete payment system, according to Mike Evans, RPh, chief pharmacy officer for Danville, Pa.-based Geisinger. “Every year,…

The FDA has issued a supplemental biologics license application to teclistamab, a Johnson & Johnson therapy, to participate in its National Priority Voucher pilot program, according to Dec. 15 news releases from the agency and the company. The application is…

CVS Caremark reached a settlement exceeding $5 million over allegations of pharmacy underpayments, according to a Dec. 8 news release from Oklahoma Attorney General Gentner Drummond. The money will go to pharmacies that filled 68,099 eligible prescriptions between January 2024…

Sanofi’s experimental multiple sclerosis drug tolebrutinib has encountered two major setbacks: a delayed regulatory decision in the U.S. and a failed late-stage clinical trial. The French drugmaker said the FDA’s decision on tolebrutinib for treating an advanced form of multiple…

Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report.  The Health Resources and Services Administration, an HHS agency, reported that 340B covered entities purchased $81.4 billion in outpatient drugs through…

Pharmacy leaders say 2026 is shaping up to be a year defined by financial volatility, regulatory pressure and workforce strain — all intensified by upcoming federal drug pricing reforms. Across organizations, the challenges are stacked. Drug pricing reforms are reshaping…

Rising uncompensated care, escalating cybersecurity and climate risks, and major shifts in the 340B and pharmacy benefit manager landscapes are prompting health systems to rethink how they deliver and finance care, according to the American Society of Health-System Pharmacists’ forecast…

Ahead of HHS’ planned 340B rebate pilot program, several healthcare organizations urged congressional leaders to cancel the pilot they say would threaten care access for low-income and rural patients.  The pilot program, slated to launch Jan. 1, will allow drug…

The FDA is considering adding a black box warning to COVID-19 vaccines — the latest development in a broader shift in how the agency approaches vaccine oversight and safety communication, according to a Dec. 12 CNN report.  Here are seven…